HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wolfgang Wick Selected Research

Glioblastoma (Glioblastoma Multiforme)

11/2022MEOX2 homeobox gene promotes growth of malignant gliomas.
5/2022Dysfunctional dendritic cells limit antigen-specific T cell response in glioma.
1/2022A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma.
1/2022DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma.
1/2022Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma.
1/2022Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study.
1/2022Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial.
1/2022Lung toxicity of lomustine in the treatment of progressive gliomas.
12/2021Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma.
3/2021Prognostic Value of microRNA-221/2 and 17-92 Families in Primary Glioblastoma Patients Treated with Postoperative Radiotherapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wolfgang Wick Research Topics

Disease

214Neoplasms (Cancer)
12/2022 - 08/2002
172Glioblastoma (Glioblastoma Multiforme)
11/2022 - 08/2002
159Glioma (Gliomas)
12/2022 - 03/2002
38Brain Neoplasms (Brain Tumor)
01/2022 - 08/2005
26Astrocytoma (Pilocytic Astrocytoma)
12/2022 - 10/2002
9Disease Progression
05/2022 - 09/2002
9Melanoma (Melanoma, Malignant)
10/2019 - 08/2002
8Oligodendroglioma
12/2022 - 10/2009
7Meningioma (Meningiomas)
01/2022 - 11/2010
7Hypoxia (Hypoxemia)
11/2015 - 08/2002
6Thrombocytopenia (Thrombopenia)
01/2022 - 07/2012
6Ischemic Stroke
09/2021 - 06/2017
6Stroke (Strokes)
09/2021 - 09/2012
6Neoplasm Metastasis (Metastasis)
01/2021 - 06/2003
6Medulloblastoma
05/2020 - 03/2002
5Lymphopenia (Lymphocytopenia)
01/2022 - 12/2010
5Multiple Sclerosis
10/2021 - 05/2010
5Neuroinflammatory Diseases
10/2019 - 09/2013
5Infections
11/2016 - 07/2006
4Lymphoma (Lymphomas)
01/2022 - 12/2010
4Residual Neoplasm
01/2022 - 04/2017
4Fatigue
01/2022 - 11/2016
4Seizures (Absence Seizure)
11/2021 - 08/2005
4Necrosis
01/2021 - 07/2006
3Neutropenia
01/2022 - 07/2012
3Spinal Muscular Atrophy (Progressive Muscular Atrophy)
10/2021 - 01/2019
3Epilepsy (Aura)
08/2020 - 09/2012

Drug/Important Bio-Agent (IBA)

73Temozolomide (Temodar)FDA LinkGeneric
01/2022 - 03/2002
47Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
05/2022 - 10/2009
46Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2010
43Bevacizumab (Avastin)FDA Link
01/2022 - 04/2010
36Proteins (Proteins, Gene)FDA Link
12/2022 - 08/2002
21DNA (Deoxyribonucleic Acid)IBA
01/2021 - 02/2006
19MethyltransferasesIBA
01/2021 - 02/2006
17Lomustine (CCNU)FDA Link
01/2022 - 09/2006
16Pharmaceutical PreparationsIBA
12/2021 - 08/2002
16Biological ProductsIBA
11/2021 - 01/2006
16EnzymesIBA
01/2021 - 05/2005
16Tryptophan (L-Tryptophan)FDA Link
01/2021 - 01/2011
15Alkylating AgentsIBA
03/2020 - 12/2005
13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2020 - 08/2002
12Messenger RNA (mRNA)IBA
01/2022 - 06/2003
11Phosphotransferases (Kinase)IBA
01/2018 - 11/2004
11Transforming Growth Factors (Transforming Growth Factor)IBA
06/2017 - 10/2004
11Transforming Growth Factor beta (TGF-beta)IBA
08/2009 - 10/2004
10VaccinesIBA
01/2022 - 08/2014
10Vincristine (Oncovin)FDA LinkGeneric
05/2020 - 10/2002
9O(6)-Methylguanine-DNA MethyltransferaseIBA
07/2014 - 09/2008
8AntigensIBA
05/2022 - 02/2015
8Immune Checkpoint InhibitorsIBA
05/2022 - 08/2015
8O-(6)-methylguanineIBA
01/2021 - 02/2006
8Procarbazine (Matulane)FDA Link
01/2020 - 10/2002
7Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2021 - 10/2011
7KynurenineIBA
01/2021 - 01/2011
7CilengitideIBA
03/2016 - 12/2009
7LigandsIBA
08/2015 - 08/2002
7CytokinesIBA
11/2014 - 11/2004
6Peptides (Polypeptides)IBA
05/2022 - 08/2002
6CarbonIBA
01/2022 - 09/2010
6Contrast MediaIBA
12/2021 - 03/2012
6ErbB Receptors (EGF Receptor)IBA
01/2021 - 10/2002
6Essential Amino AcidsIBA
01/2020 - 09/2012
6AntibodiesIBA
03/2019 - 04/2012
6CaspasesIBA
02/2011 - 03/2002
5IonsIBA
01/2022 - 10/2010
5RNA (Ribonucleic Acid)IBA
01/2022 - 01/2018
5Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021 - 12/2013
5Protons (Proton)IBA
09/2019 - 09/2010
5IntegrinsIBA
03/2016 - 12/2009
5enzastaurinIBA
03/2016 - 09/2008
4ParaffinIBA
12/2022 - 01/2012
4Neoplasm Antigens (Tumor Antigens)IBA
05/2022 - 11/2018
4SteroidsIBA
01/2022 - 12/2010
4GadoliniumIBA
12/2021 - 01/2017
4Anticonvulsants (Antiepileptic Drugs)IBA
11/2021 - 08/2005
4Codon (Codons)IBA
01/2021 - 12/2010
4APTIBA
09/2019 - 06/2018
4AmidesIBA
09/2019 - 05/2015
4Histones (Histone)IBA
01/2018 - 05/2006
4Matrix Metalloproteinases (MMPs)IBA
01/2018 - 12/2004
4Small Interfering RNA (siRNA)IBA
01/2015 - 10/2004
3Formaldehyde (Formol)FDA Link
12/2022 - 01/2012
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2022 - 01/2020
3Protein Subunit VaccinesIBA
05/2022 - 01/2021
3B7-H1 AntigenIBA
05/2022 - 08/2015
3Glial Fibrillary Acidic ProteinIBA
01/2021 - 10/2014
3ProteomeIBA
01/2021 - 11/2018
3Amino AcidsFDA Link
01/2021 - 01/2017
3Oxygen (Dioxygen)IBA
10/2020 - 02/2017

Therapy/Procedure

105Therapeutics
05/2022 - 08/2002
75Radiotherapy
04/2022 - 09/2002
64Drug Therapy (Chemotherapy)
01/2022 - 09/2002
26Immunotherapy
05/2022 - 01/2006
25Chemoradiotherapy
01/2022 - 06/2008
5Thrombectomy
09/2021 - 01/2018
4Precision Medicine
01/2021 - 01/2010
4Salvage Therapy
01/2020 - 09/2012
4Re-Irradiation
12/2019 - 10/2010
4Heavy Ion Radiotherapy
01/2018 - 09/2010
3Lasers (Laser)
01/2021 - 10/2017